Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Divesting Three Units, Shifts Focus on Health Sciences, Photonics

This article has been updated from a previous version to correct the amount PerkinElmer expects from the sale of its semiconductor and fluid scinces business.

 

NEW YORK, Oct. 7 (GenomeWeb News) - PerkinElmer will shift its strategic focus on the health sciences and photonic markets by selling its aerospace, semiconductor, and fluid-testing businesses, the company said yesterday.

 

"The proceeds will help us build our growth platforms, with particular emphasis on genetic screening, medical imaging, molecular medicine, and service," PE chairman and CEO Gregory Summe said in a company statement.

 

PE will sell its aerospace business to Eaton for approximately $333 million, and is in discussions to sell its semiconductor and fluid testing businesses by the end of the year. The company said it expects to gain a total of $400 million from the sale of the three businesses.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.